Literature DB >> 36171513

NIR Spectroscopy as an Online PAT Tool for a Narrow Therapeutic Index Drug: Toward a Platform Approach Across Lab and Pilot Scales for Development of a Powder Blending Monitoring Method and Endpoint Determination.

Sameer Talwar1,2, Pallavi Pawar3,4, Huiquan Wu5, Koushik Sowrirajan6, Suyang Wu6, Benoît Igne1, Richard Friedman7, Fernando J Muzzio3, James K Drennen8.   

Abstract

An online near-infrared (NIR) spectroscopy platform system for real-time powder blending monitoring and blend endpoint determination was tested for a phenytoin sodium formulation. The study utilized robust experimental design and multiple sensors to investigate multivariate data acquisition, model development, and model scale-up from lab to manufacturing. The impact of the selection of various blend endpoint algorithms on predicted blend endpoint (i.e., mixing time) was explored. Spectral data collected at two process scales using two NIR spectrometers was incorporated in a single (global) calibration model. Unique endpoints were obtained with different algorithms based on standard deviation, average, and distributions of concentration prediction for major components of the formulation. Control over phenytoin sodium's distribution was considered critical due to its narrow therapeutic index nature. It was found that algorithms sensitive to deviation from target concentration offered the simplest interpretation and consistent trends. In contrast, algorithms sensitive to global homogeneity of active and excipients yielded the longest mixing time to achieve blending endpoint. However, they were potentially more sensitive to subtle uniformity variations. Qualitative algorithms using principal component analysis (PCA) of spectral data yielded the prediction of shortest mixing time for blending endpoint. The hybrid approach of combining NIR data from different scales presents several advantages. It enables simplifying the chemometrics model building process and reduces the cost of model building compared to the approach of using data solely from commercial scale. Success of such a hybrid approach depends on the spectroscopic variability captured at different scales and their relative contributions in the final NIR model.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  algorithms; endpoint determination; engineering platform system; narrow therapeutic index (NTI) drug; partial least squares (PLS); powder blending; principal component analysis (PCA); process analytical technology (PAT); process monitoring; scale-up

Mesh:

Substances:

Year:  2022        PMID: 36171513     DOI: 10.1208/s12248-022-00748-4

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   3.603


  39 in total

1.  V-blender segregation patterns for free-flowing materials: effects of blender capacity and fill level.

Authors:  Albert Alexander; Troy Shinbrot; Barbara Johnson; Fernando J Muzzio
Journal:  Int J Pharm       Date:  2004-01-09       Impact factor: 5.875

Review 2.  What are narrow therapeutic index drugs?

Authors:  G Levy
Journal:  Clin Pharmacol Ther       Date:  1998-05       Impact factor: 6.875

Review 3.  The determination and interpretation of the therapeutic index in drug development.

Authors:  Patrick Y Muller; Mark N Milton
Journal:  Nat Rev Drug Discov       Date:  2012-08-31       Impact factor: 84.694

4.  Phenytoin: pharmacokinetics and bioavailability.

Authors:  R Gugler; C V Manion; D L Azarnoff
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

Review 5.  The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.

Authors:  Giuseppe Borgheini
Journal:  Clin Ther       Date:  2003-06       Impact factor: 3.393

Review 6.  Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.

Authors:  P J Neuvonen
Journal:  Clin Pharmacokinet       Date:  1979 Mar-Apr       Impact factor: 6.447

7.  Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester.

Authors:  Lin Xie; Huiquan Wu; Meiyu Shen; Larry L Augsburger; Robbe C Lyon; Mansoor A Khan; Ajaz S Hussain; Stephen W Hoag
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

8.  Comparative bioavailability of a generic phenytoin and Dilantin.

Authors:  D H Rosenbaum; A J Rowan; L Tuchman; J A French
Journal:  Epilepsia       Date:  1994 May-Jun       Impact factor: 5.864

9.  Incorporation of physiologically based pharmacokinetic modeling in the evaluation of solubility requirements for the salt selection process: a case study using phenytoin.

Authors:  Po-Chang Chiang; Harvey Wong
Journal:  AAPS J       Date:  2013-08-14       Impact factor: 4.009

Review 10.  Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach.

Authors:  Rachel G Greenberg; Chiara Melloni; Huali Wu; Daniel Gonzalez; Lawrence Ku; Kevin D Hill; Christoph P Hornik; Michael Cohen-Wolkowiez; Jeffrey T Guptill
Journal:  Clin Neuropharmacol       Date:  2016 Sep-Oct       Impact factor: 1.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.